Debt-to-equity of Petros Pharmaceuticals, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Petros Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
Petros Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -552%, a 345% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Petros Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	-552%	-778%	-345%	30 Sep 2025
Q2 2025	-694%	-934%	-388%	30 Jun 2025
Q1 2025	-1344%	-1557%	-733%	31 Mar 2025
Q4 2024	528%	+350%	+198%	31 Dec 2024
Q3 2024	225%	+75%	+49%	30 Sep 2024
Q2 2024	241%	+144%	+149%	30 Jun 2024
Q1 2024	212%	+138%	+186%	31 Mar 2024
Q4 2023	177%	+112%	+173%	31 Dec 2023
Q3 2023	151%	+83%	+122%	30 Sep 2023
Q2 2023	97%	+13%	+16%	30 Jun 2023
Q1 2023	74%	-39%	-35%	31 Mar 2023
Q4 2022	65%	-93%	-59%	31 Dec 2022
Q3 2022	68%	-155%	-70%	30 Sep 2022
Q2 2022	84%			30 Jun 2022
Q1 2022	114%			31 Mar 2022
Q4 2021	158%			31 Dec 2021
Q3 2021	223%			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.